Skip to main content
. 2022 Oct 31;2022:9992881. doi: 10.1155/2022/9992881

Table 2.

Impact of bacterial and/or fungal coinfections among ICU COVID-19 patients.

Variable Patient's outcomes p value
Survived Died
Sex Male 42.9% 53.8% 0.466
Female 57.1% 46.2%

Age Less than 29 years 0.0% 5.1% 0.642
29–49 years 14.3% 5.1%
50–65 years 0.0% 15.4%
66–70 years 14.3% 7.7%
More than 70 years 71.4% 66.7%

Cause of coinfections Fungi (sole) 14.3% 2.6% 0.366
Dual (bacterial and fungal coinfections) 0.0% 2.6%
Bacteria 85.7% 94.9%
Monobacterial 0.0% 24.3% <0.001
Multibacterial 100.0% 75.7%

Antimicrobial susceptibility test Antibiotic resistance Yes 28.6% 51.3% 0.149
No 71.4% 48.7%
Resistance to antibiotics Oxacillin resistance Yes 28.6% 38.5% 0.618
No 71.4% 61.5%
Methicillin resistance Yes 14.3% 15.4 0.268
No 85.7% 84.6%

Inflammatory biomarkers (mean ± SD) Procalcitonin (g/dl) 0.93 ± 0.47 22.77 ± 0.87 0.585
C-reactive protein (mg/L) 48.15 ± 0.36 95.88 ± 0.93 0.404
Ferritin (ng/ml) 838.18 ± 0.98 4230.96 ± 0.78 0.692
D-dimer (ng/ml) 607.00 ± 2.03 9200.40 ± 7.50 0.446
White blood cells count (×109 cells/L) 12.63 ± 5.12 18.73 ± 3.48 0.586
Neutrophils counts (%) 89.75 ± 1.26 81.48 ± 7.89 0.326
Lymphocyte counts (%) 5.50 ± 1.53 13.07 ± 2.54 0.356

Site of coinfection Upper respiratory infection 28.6% 13.0% 0.171
Lower respiratory infection 14.3% 24.1%
Bacteremia 42.9% 63.0%
Meningitis 14.3% 0.0%

Total 15.2% 84.8%

Normal range: procalcitonin: less than 0.5 ng/ml: low risk of severe sepsis, 0.5–2.0 ng/ml: clinical suspicion of sepsis, more than 2.0–10 ng/ml: high risk of severe sepsis, more than 10 ng/ml: high likelihood of septic shock; C-reactive protein: less than 5.0 mg/L; ferritin: male: 22–322 ng/ml, female: 10–291 ng/ml; D-dimer: less than 500 ng/ml; globulin: 2–3 g/dl; white blood cell count: 4.5–11 × 109/L; neutrophil count: 30–75%; lymphocytes: 20–40%. Statistically significant at p < 0.05.